We are a research and development firm focusing on bringing forward a medication for opioid use disorder. Our firm is developing a sustained-release, subcutaneous naltrexone implant that will deliver the drug for at least six months. Once approved, this will be the first new treatment for opioid use disorder to come on the market since 2006. Pre-clinical studies have shown that our product is safe and effective. Phase 1 human clinical studies are projected to begin in Q2 2023.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 6511 Deer Pointe Dr, Salisbury,maryland 21804,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://akysomed.com
- Keywords
- Research and Development, Opioid use disorder, Addiction, Biotech, Pharmaceutical, Fentanyl, CMC, Start-up, Drug Addiction, Naltrexone, Methadone, Medical Device.
- HQ
- Salisbury, Maryland
Akyso Questions
Akyso's website is http://akysomed.com
Akyso's LinkedIn profile is https://www.linkedin.com/company/akyso
Akyso has
3 employees.
View email and phone details for 3
employees at Akyso.
Akyso's industry is
Biotechnology Research
Akyso's categories are Biotechnology Research
Akyso's founding year is 2014
